Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Novo Nordisk patent opposition analysis

Get Patent Opposition Report for Novo Nordisk

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Novo Nordisk

Explore patent oppositions filed by Novo Nordisk against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3056568Methods For Controlling Blood Pharmacokinetics Of AntibodiesCHUGAI SEIYAKU KABUSHIKI KAISHAJun 15, 2022
EP3653223Device For The Oral Delivery Of Therapeutic CompoundsRANI THERAPEUTICSMay 25, 2022
EP1869065A Method Of Weak Partitioning ChromatographyWYETHFeb 5, 2021
EP3461478Swallowable Drug Delivery DeviceRANI THERAPEUTICSJan 21, 2021
EP2544668Therapeutic Agent Preparations For Delivery Into A Lumen Of The Intestinal Tract Using A Swallowable Drug Delivery DeviceINCUBE LABSApr 16, 2020
EP2515992Swallowable Drug Delivery Device And Methods Of Drug DeliveryINCUBE LABSJul 9, 2019
EP2708559Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 19, 2018
EP2786657A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSNov 6, 2018

Latest patents of Novo Nordisk opposed by its competitors

Explore Novo Nordisk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3300721Jan 8, 2025Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices5
EP2729202Nov 6, 2024Drug Delivery Injection Pen With Add-On Dose Capturing And Display Module1
EP4054620May 29, 2024Glp-1 Receptor Agonists In Dementia2
EP3474820Feb 7, 2024Glp-1 Compositions And Uses Thereof8
EP3250191Jan 17, 2024Tablets Comprising Glp-1 Agonist And Enteric Coating1
EP3488857Oct 4, 2023Compositions Of Glp-1 Peptides And Preparation Thereof5
EP3542790Sep 13, 2023Compositions Comprising A Delivery Agent And Preparation Thereof7
EP3746111Jul 19, 2023Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant4
EP3870213Jun 7, 2023Stable Semaglutide Compositions And Uses Thereof1
EP3634468Dec 14, 2022Solid Compositions For Oral Administration1

Top competitors of Novo Nordisk